These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14502678)

  • 1. Botulinum toxin B reduces sialorrhea in parkinsonism.
    Racette BA; Good L; Sagitto S; Perlmutter JS
    Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea.
    Su CS; Lan MY; Liu JS; Chang CC; Lai SL; Wu HS; Chen SS; Chang YY
    Acta Neurol Taiwan; 2006 Sep; 15(3):170-6. PubMed ID: 16995596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
    Chinnapongse R; Gullo K; Nemeth P; Zhang Y; Griggs L
    Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin for treatment of parkinsonian sialorrhea.
    Friedman A; Potulska A
    Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
    Verma A; Steele J
    Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands.
    Turk-Gonzales M; Odderson IR
    Neurorehabil Neural Repair; 2005 Mar; 19(1):58-61. PubMed ID: 15673844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
    Ondo WG; Hunter C; Moore W
    Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
    Fuster Torres MA; Berini Aytés L; Gay Escoda C
    Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.
    Jackson CE; Gronseth G; Rosenfeld J; Barohn RJ; Dubinsky R; Simpson CB; McVey A; Kittrell PP; King R; Herbelin L;
    Muscle Nerve; 2009 Feb; 39(2):137-43. PubMed ID: 19145653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
    Tan EK
    Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease.
    Contarino MF; Pompili M; Tittoto P; Vanacore N; Sabatelli M; Cedrone A; Rapaccini GL; Gasbarrini G; Tonali PA; Bentivoglio AR
    Parkinsonism Relat Disord; 2007 Jul; 13(5):299-303. PubMed ID: 16807056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.
    Steinlechner S; Klein C; Moser A; Lencer R; Hagenah J
    Psychopharmacology (Berl); 2010 Jan; 207(4):593-7. PubMed ID: 19823807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    J Neurol; 2009 Apr; 256(4):563-7. PubMed ID: 19401804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands.
    Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C; Beuche W
    Laryngoscope; 2002 Jan; 112(1):82-6. PubMed ID: 11802043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of sialorrhea with botulinum toxin].
    Jost WH; Bäumer T; Laskawi R; Spittau B; Steffen A; Winterholler M
    Fortschr Neurol Psychiatr; 2019 Oct; 87(10):554-563. PubMed ID: 31344747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
    Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C
    J Oral Maxillofac Surg; 2003 Apr; 61(4):454-7. PubMed ID: 12684962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.